Prophylactic Anti-allergic Drug Administration to Prevent Docetaxel and Cyclophosphamide-induced Skin Toxicity: Sub-analysis of a Multiinstitution Neoadjuvant Chemotherapy Trial in Primary Breast Cancer Patients

Nakatsukasa K^1*, Koyama H², Ouchi Y², Sakaguchi K¹, Matsuda T³, Fujiwara I⁴, Kadotani Y⁵, Kawakami S⁶, Konishi E⁷ and Taguchi T¹

¹Department of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan

²Nara City Hospital, Nara, Japan

³Saiseikai Kyoto Hospital, Kyoto, Japan

⁴Ayabe City Hospital, Ayabe, Japan

⁵Aiseikai Yamashina Hospital, Kyoto City, Japan

⁶Fukuchiyama City Hospital, Kyoto, Japan

⁷Department of Surgical Pathology, Kyoto Prefectural University of Medicine, Kyoto, Japan

^*Corresponding Author: Nakatsukasa K, MD, Department of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachi-hirokoji, Kamigyo-ku, Kyoto City, 602-8566, Japan, Tel: +81-75-251-5534, Fax: +81-75-251-0270 Email: